RAZA SAIYED ATIQ 4

What Happened

• Raza Saiyed Atiq, a director of Arteris, sold a total of 70,000 shares in open-market transactions on June 1, 2026, generating approximately $2,521,103 in proceeds.
  • 66,400 shares sold at a weighted average price of $35.99 for $2,389,882 (sales occurred at individual prices from $35.34 to $36.33).
  • 3,600 shares sold at a weighted average price of $36.45 for $131,221 (sales occurred at individual prices from $36.34 to $36.56).
• These were sales (not purchases); sales are often routine and do not necessarily signal company outlook.

Key Details

• Transaction date: June 1, 2026; Form 4 filed June 3, 2026 (filed within the typical 2-business-day window).
• Total shares sold: 70,000; total proceeds: about $2.52 million.
• Shares sold pursuant to a 10b5-1 trading plan adopted November 7, 2025 (prearranged plan — see footnote F1).
• Shares sold were held in the "Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust," for which the reporting person is trustee (footnote F3).
• Reported prices are weighted averages; individual sale price ranges provided in footnotes (F2 and F4). The filing offers to provide per-trade price breakdown on request.
• Shares owned after the transactions are not specified in the provided filing summary.

Context

• The sales were executed under a 10b5-1 plan, which typically means trades were pre-scheduled and not based on contemporaneous insider knowledge.
• For retail investors, purchases generally carry more bullish informational value than routine sales; however, the size (~$2.5M) is material and worth noting as part of insider activity monitoring.